RealPharma: Conversations with Pharma Pathfinders
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
Episodes
Good Intentions, Bad Outcomes: Rethinking Healthcare Policy with Deborah Williams
When Healthcare Policy Incentives Backfire: 340B, Hospital Pricing, MFN, and Drug Affordability with Deborah Williams
Healthcare policies are often evaluated by what they are intended to accomplish. But what happens when the incentives created by those policies produce very different results?
In this episode of RealPharma, Ian Wendt and Dr. Na-Ri Oh speak with longtime health policy expert Deborah
The New Biopharma Talent Market: AI, M&A, and a K-Shaped Recovery
Episode Summary
In this episode of Real Pharma, hosts Na-Ri Oh and Ian Wendt sit down with Kristiaan Rawlings, Executive Director at EPM Scientific, to unpack what is really happening in the biopharma talent market right now. From the surprising resurgence of market access hiring to the growing influence of AI in recruiting and candidate preparation, this conversation explores the forces reshaping
What Farmers Know About Cancer with Chris Gregg
🧠 Episode Summary
What if we’ve been thinking about cancer all wrong?
In this deeply personal and paradigm-shifting episode of RealPharma, hosts Dr. Na-Ri Oh and Ian Wendt sit down with Dr. Christopher Gregg—neuroscientist, entrepreneur, and stage 4 cancer patient—to explore a bold new vision for cancer care.
Dr. Gregg shares how his own diagnosis sparked a radical rethink of oncology: moving away
The Opioid Reckoning (Part 2): Paul Farrell Jr.
The Opioid Reckoning (Part 2): Litigation, Accountability, and the Fight for Justice with Paul T. Farrell Jr.
In Part 2 of our deep dive into the opioid crisis, hosts Dr. Na-Ri Oh and Ian Wendt continue their conversation with Paul T. Farrell Jr., the West Virginia attorney who helped lead the historic national opioid litigation.
This episode moves beyond the legal strategy discussed in Part 1 and
The Opioid Reckoning (Part 1): Paul Farrell Jr.
The Opioid Reckoning (Part 1): Paul Farrell Jr. on Litigation, Accountability, and the System That Failed
West Virginia has had the highest drug overdose death rate in the United States for over a decade. In a state with fewer than 2 million people, 780 million prescription opioids were distributed in just six years.
For Paul Farrell Jr., a Huntington, West Virginia native and mass tort attorney,
Ending The Diagnostic Odyssey with Josh Resnikoff
Ending the Diagnostic Odyssey: Rare Disease, Employers & Reimagining Health Plans
Hosts: Na-Ri Oh & Ian Wendt
Guest: Joshua Resnikoff, Founder & CEO, Sunstone Health
Episode Overview
What if the biggest innovation in rare disease wasn’t a new drug—but a new way to navigate the system?
In this episode, Na-Ri and Ian sit down with Joshua Resnikoff, biomedical engineer turned founder of
Beyond Survival: Why Empathy Is the Missing Prescription in Pharma with Matthew Zachary
🎙️ Beyond Survival: Why Empathy Is the Missing Prescription in Pharma
Episode Summary:
In this no-holds-barred conversation, Na-Ri Oh and Ian Wendt sit down with Matthew Zachary—brain cancer survivor, founder of Stupid Cancer, host of Out of Patients, and a relentless disruptor in patient advocacy.
At 21, Matthew was diagnosed with brain cancer and faced a life-altering decision: take chemothera
Breaking the Silence: Why Pharma Needs to Speak Up with Brian Reid
🎙️ Real Pharma – Episode Title: Breaking the Silence: Why Pharma Needs to Speak Up
Hosts: Na-Ri Oh & Ian Wendt
Guest: Brian Reid, Founder & Principal at Reid Strategic
🔍 Episode Summary:
In this episode of Real Pharma, Na-Ri and Ian sit down with Brian Reid—a healthcare communicator, strategist, and former journalist who's worked across government, pharma, and media—to explore a provoca
Formulation as Strategy: Why CDMOs Matter More Than Ever
Episode Title: Formulation as Strategy: Why CDMOs Matter More Than Ever
Guest: Elizabeth Hickman, President & CEO, Austin Pharmaceutics
Episode Overview
In this episode of RealPharma, hosts Nari Oh and Ian Wendt sit down with Elizabeth Hickman, President and CEO of Austin Pharmaceutics, to unpack one of the most critical—and often misunderstood—elements of drug development: formulation and th
Untangling the IRA with Emma Cousin
🎧 Hosts: Na-Ri Oh & Ian Wendt
🎓 Special Guests: Emma Cousin (PhD Candidate, Choice Institute – UW), Amos Fung (RealPharma Intern & Student Pharmacist)
🔍 Episode Summary:
In this thought-provoking episode, hosts Na-Ri Oh and Ian Wendt sit down with Emma Cousin, a PhD candidate at the Choice Institute, University of Washington, to unpack the real-world implications of the Inflation Reductio
Reinventing Cell Therapy with Acoustics
Reinventing Cell Therapy with Acoustics, Microfluidics & High-Throughput Engineering
In this episode, hosts Na-Ri Oh and Ian Wendt sit down with Dr. Andrew Gray — immune cell engineer, biotech founder, venture capitalist, and CEO of CellEcho — to explore how a new acoustic-powered gene-delivery platform may redefine the boundaries of cell therapy.
The conversation spans the current state of th
Food as Medicine: Promise, Pitfalls, and the Politics of the Plate
👩🔬👨⚕️ Hosts:
Na-Ri Oh & Ian Wendt
🎧 Guest:
Dr. Ron Shigeta – Biotech visionary, co-founder of IndieBio, and food innovation expert.
🧬 Episode Summary:
In this deeply insightful and refreshingly candid episode, Ian and Nari welcome back biotech veteran Dr. Ron Shigeta to explore the evolving landscape where food, health, and biotech collide. From the collapse of the lab-grown meat hype cycle
From Job Search to Power Move: How Top Talent’s Playing 2025
🎙 Episode Title: From Job Search to Power Move: How Top Talent’s Playing 2025
🧠 Guests: Kristiaan Rawlings, Executive Director at EPM Scientific
🎧 Hosts: Na-Ri Oh & Ian Wendt
Episode Summary
Layoffs. AI. Resume black holes. The biopharma hiring market feels noisy—and not in a good way. But beneath the doomscrolling, there’s a more nuanced story unfolding.
In this episode, Kristiaan Rawlings
Where Policy Meets the Pharmacy Counter
Where Policy Meets the Pharmacy Counter
Featuring Congressman Jake Auchincloss
Episode Summary
In this episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with Congressman Jake Auchincloss (MA-04) to dissect the tangled web of policy, profit, and politics driving America’s drug pricing system. From pharmacy benefit managers (PBMs) to the politics of tariffs, this discussion explores the
Conversations, Not Campaigns: The Art of Authentic Engagement in Healthcare
Episode Title:
“Conversations, Not Campaigns: The Art of Authentic Engagement in Healthcare”
🗣️ Episode Summary
In this episode, hosts Dr. Na-Ri Oh and Ian Wendt sit down with Colin Hung — healthcare technologist, marketing strategist, and co-founder of the long-running #HCLDR (Healthcare Leadership) Twitter community. Colin shares his journey from biomedical engineering to becoming one of the
Building the Highway for AI in Pharma: A Conversation with Ilya Burkov
🎙️ Episode Title:
Building the Highway for AI in Pharma: A Conversation with Ilya Burkov
📍 Episode Summary
In this episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with Dr. Ilya Burkov, Head of AI Cloud at Nebius, to explore the critical infrastructure enabling the AI revolution in drug development.
While the headlines often focus on the promise of AI, Ilya brings us backstage—where
Inside the CMC Black Box: A Deep Dive with Reza Oliyai
🎙️ Episode Title:
Inside the CMC Black Box: A Deep Dive with Reza Oliyai
🧾 Show Notes:
What exactly is CMC — and why is it behind more FDA rejections than any other category?
In this episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with Dr. Reza Oliyai, former SVP of Pharmaceutical & Biologics Operations at Gilead Sciences, and now Founder & CEO of Oliyai Consulting, to demys
Can We Say That? Dara Katcher Levy on the AdPromo Regulatory Landscape
In this episode of RealPharma, Ian Wendt and Na-Ri Oh sit down with Dara Katcher Levy, a regulatory attorney at Hyman, Phelps & McNamara, P.C.—widely regarded as one of the nation’s top firms in food and drug law. Dara brings decades of expertise in promotional review, labeling negotiations, and post-market compliance, helping life sciences companies navigate the complex world of FDA regulatio
From Rock Star to Rare Disease Revolutionary: Casey McPherson’s Fight for His Daughter’s Life
Episode Title: From Rock Star to Rare Disease Revolutionary: Casey McPherson’s Fight for His Daughter’s Life
In this deeply personal and inspiring conversation, hosts Na-Ri Oh and Ian Wendt sit down with Casey McPherson, founder and CEO of AlphaRose Therapeutics—and acclaimed recording artist—to explore how one father’s determination to save his daughter’s life is shaking up the rare disease drug
Behind the PBM Curtain: Antonio Ciaccia Exposes the Game
Episode Title: Behind the PBM Curtain: Antonio Ciaccia Exposes the Game
Show Notes:
In this compelling episode of Real Pharma, hosts Na-Ri Oh and Ian Wendt welcome back Antonio Ciaccia, CEO of 46brooklyn Research and President of 3 Axis Advisors, for a hard-hitting discussion on the power and pitfalls of pharmacy benefit managers (PBMs).
PBMs remain one of the most opaque and influential forces
340B or Bust: Is This Program Failing the Sick
🎙️ 340B or Bust: Is This Program Failing the Sick?
This week on Real Pharma, hosts Dr. Na-Ri Oh and Ian Wendt dive into the tangled world of 340B with returning guest William “Bill” Sarraille—one of the most respected voices in healthcare law, an active patient advocate, and a rare disease patient himself.
The 340B Drug Pricing Program was intended to help vulnerable patients by requiring drug m
Paging Dr. ChatGPT with Bryce Sady
Episode Title:
Paging Dr. ChaptGPT with Bryce Sady
AI Adoption in Healthcare: Navigating the Present and Shaping the Future with Bryce Sady
Episode Description:
On today's insightful episode of RealPharma, hosts Dr. Na-Ri Oh and Ian Wendt sit down with Bryce Sady, Vice President of Product Development at PSL Group's Medical Education and Communications Division, a veteran innovator at the inters
Hiring Heat Check: What’s Hot in Biotech + Pharma Talent in Mid-2025
Episode Title: “Hiring Heat Check: What’s Hot in Biotech + Pharma Talent in Mid-2025”
🎙️ Hosts: Ian Wendt & Na-Ri Oh
🎧 Guest: Kristiaan Rawlings, Executive Recruiter at EPM Scientific
Episode Overview:
This week, fan favorite Kristiaan Rawlings returns to RealPharma to give us the raw and real insights on pharma and biotech hiring trends as we hit the midpoint of 2025. From compensation cur
The Future of Biotech
🎙 Episode Title: The Future of Biotech
Guest: Andrew Craig, Founder of Plain English Finance | Author of Our Future is Biotech
📌 Episode Summary
In this bold and wide-ranging conversation, Ian Wendt and Na-Ri Oh sit down with Andrew Craig—British investor, entrepreneur, and author—to explore how biotechnology is poised to shape the next century in the same way physics and computing shaped the
Rooted in Results: The Future of Functional Medicine with Dr. Erica Armstrong
🎙 Episode Title: Rooted in Results: The Future of Functional Medicine with Dr. Erica Armstrong
🧬 Episode Summary
In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Dr. Erica Armstrong, board-certified family medicine physician and founder of Root Functional Medicine, to explore the promise, challenges, and evolution of functional medicine. Dr. Armstrong discusses how Root’s systems-bas
Cracking the Code on Patient Engagement: Conversational AI with Dan Fox
🎙️ RealPharma Podcast
Episode Title: Cracking the Code on Patient Engagement: Conversational AI with Dan Fox
🗓️ Release Date: May 5, 2025
🎧 Hosts: Dr. Na-Ri Oh & Ian Wendt
🎤 Guest: Dan Fox, Managing Director of Healthcare at Drips
Episode Summary:
In this eye-opening episode, we welcome Dan Fox, a trailblazer in AI-powered patient communication, to explore how proactive outreach and conversat
Healthcare Leadership and Resilience with Grace Magedman
In this powerful and deeply human episode of RealPharma, we’re joined by Grace Magedman, PharmD—former Chief Pharmacy Officer at Children’s Hospital of Orange County, functional medicine practitioner, and founder of The Magidman Group.
Grace takes us inside her 20+ years of hospital pharmacy leadership, where she navigated high-stakes medication decisions, complex implementation of rare disease th
Bridging the Gap in Cancer Care Part 2: Dr. Yaming Wang on Innovation, Access, and the Power of Knowledge
In this second part of our deep dive into hematology and oncology, we welcome back Dr. Yaming Wang, founder of Alphabet Health LTD and an expert in molecular oncology, pharmaceutical strategy, and medical education. Building on our previous discussion, we explore cutting-edge advancements in cancer diagnostics and therapies, including the promise and limitations of liquid biopsies, the evolution o
Bridging the Gap in Cancer Care Part1: Dr. Yaming Wang on Innovation, Access, and the Power of Knowledge
🎙 RealPharma Podcast – Oncology Part 1: Understanding the Cancer Universe with Dr. Yaming Wang
Cancer is one of the most complex and pressing challenges in modern medicine. But how much do we really understand about it? In this first episode of our two-part oncology deep dive, we sit down with Dr. Yaming Wang, founder of Alphabet Health, to break down the fundamentals of oncology and hematology.
F
The Future of Healing: Stem Cells, Regenerative Medicine & What’s Next
In this episode of Real Pharma, hosts Na-Ri Oh and Ian Wendt engage with Joshua Kettner, co-founder of DreamBody Clinic, to explore the intricacies of stem cell therapy.
They discuss the clinic's unique approach to regenerative medicine, the science behind mesenchymal stem cells, and the various applications and limitations of this therapy. The conversation also delves into the regulatory challeng
Psychedelic Renaissance: Insights from Ethnopharmacologist Dennis McKenna
In this riveting episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with the renowned ethnopharmacologist, Dennis McKenna, to explore the profound intersection of nature, science, and healing. From Dennis’s storied journey into the world of plant medicines to the evolving landscape of psychedelic therapies, this conversation is as thought-provoking as it is inspiring.
Key Topics Discuss
Unlocking Pharma Career Success in 2025: Insights from Kristiaan Rawlings
Year-End Wrap-Up with Kristiaan RawlingsIn this episode of the Real Pharma Podcast, hosts Ian Wendt and Na-Ri Oh welcome back frequent guest Kristiaan Rawlings, a seasoned commercial pharmaceutical recruiter, for a year-end reflection on the pharmaceutical job market in 2024 and a look ahead to 2025. The discussion highlights key trends, challenges, and opportunities for candidates and employers a
Jason Scharf Explains How the Bio-Innovation Tech Stack Is Changing Everything
In this episode of the Real Pharma Podcast, hosts Ian Wendt and Dr. Na-Ri Oh and guest Jason Scharf delve into the evolving landscape of TechBio, exploring its definition, the rise of bio innovation, and the challenges and opportunities it presents.
They discuss the shift from traditional drug development methods to innovative approaches driven by technology, the importance of adapting business mo
Radiopharmaceuticals: The Future of Precision Medicine with Roger Estafanos
In this conversation, Roger Estafanos discusses the evolving field of radiopharmaceuticals, highlighting their transformative impact on cancer treatment and patient care.
He explains the targeted nature of these therapies, the importance of personalized medicine, and the challenges faced in regulatory processes and patient safety. The discussion also covers the role of different radioisotopes, the
Decoding Digital Marketing: Insights from Aaron Burnett
In this conversation, Aaron Burnett, from Wheelhouse DMG, discusses the rapid evolution of digital marketing in the healthcare sector, emphasizing the importance of data strategy and compliance with regulations like HIPAA.
He highlights the shift from third-party data reliance to first-party data utilization, which enhances marketing effectiveness and patient engagement.
The discussion also covers
AI Recap - Andree Bates Episode Review
In this latest episode of RealPharma, we’re diving back into the fascinating world of AI in pharma, breaking down all the insights from our conversation with the brilliant Andree Bates! If you missed it or want to catch the highlights, this episode serves up a concise, punchy summary covering everything from predictive analytics to patient outcomes and beyond.
But there's a twist.
Our hosts, this
Mastering Omnichannel: Insights with Philip Vyt
In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Philip Vyt, a renowned expert in omnichannel strategy and founder of Shyft, a consultancy specializing in omnichannel approaches for biopharma.
They delve into the key concepts behind omnichannel and its distinction from multichannel, emphasizing the centrality of healthcare professionals (HCPs) in engagement strategies. Philip breaks down
Staying Ahead In Your Pharma Career with Kristiaan Rawlings
In this episode, Dr. Na-Ri and Ian Wendt welcome back Kristiaan Rawlings, from EPM Scientific to discuss the latest trends in pharma and biotech hiring.
They explore the key drivers of hiring, the impact of AI and advanced analytics, and the evolving expectations of candidates. Kristiaan emphasizes the importance of change agents in the industry and shares insights on the optimistic outlook for sm
Opioid Epidemic: Michael Barnes on the Fight to End the Crisis
In this episode, Ian Wendt and Dr. Na-Ri Oh interview Michael C. Barnes, Chairman of the Center for US Policy, about the US opioid crisis.
They discuss the evolution of US policy on opioids, the impact of the crisis on different communities, the role of legislation and harm reduction, the accountability of the pharmaceutical industry, barriers to accessing treatment, and the importance of advocacy
Medical Affairs Reimagined: Danny McBryan on Shaping Pharma’s Future
Danny McBryan, an executive leader in the pharmaceutical industry, discusses the evolving role of medical affairs in healthcare.
He highlights the importance of medical affairs in conveying the science of pharmaceutical companies and translating complex data into a meaningful narrative for healthcare providers, payers, patients, and policymakers.
McBryan emphasizes the need for medical affairs to
Empowering the Patient Voice: A Deep Dive into Advocacy with Stacey Tinianov
In this episode, Na-Ri and Ian interview Stacey Tinianov, an independent patient advocate and founder of Advocates for Collaborative Education.
They discuss the importance of patient advocacy, the role of digital health, and the future of patient engagement.
Stacey shares her personal journey into patient advocacy and highlights the gaps in knowledge and understanding she experienced as a breast c
AI Revolution: Transforming Biopharma with Andree Bates
Summary
Dr. Andrée Bates, a pioneering force in the realm of artificial intelligence within the pharmaceutical industry, shares insights on the evolving role of AI in pharma, the future of healthcare innovation, and her advocacy for women in leadership.
She discusses the early days of AI in pharma, the challenges faced, and the evolution of AI terminology. Dr. Bates also explores the application o
Unmasking PBMs: Antonio Ciaccia Exposes the Hidden Power Players in Healthcare
Summary
In this episode, Dr. Na-Ri Oh and Ian Wendt discuss Pharmacy Benefit Managers (PBMs) and their impact on drug pricing and patient access to medications.
They are joined by Antonio Ciaccia, CEO of 46 Brooklyn Research and president of 3 Access Advisors, which provides insights into the role of PBMs in the drug supply chain.
The conversation highlights the consolidation of power among the to
340B Controversy: Who Really Benefits from Drug Discounts?
In this episode, Dr. Na-Ri Oh and Ian Wendt discuss the 340B drug pricing program with guest William Sarraille, a healthcare law expert.
They explore the origins of the program and its intended purpose. However, the program has grown exponentially and is now the second largest drug program in the country. Bill raises concerns about the lack of transparency and accountability in the program, as wel
From Biotech Breakthroughs to Food Tech Revolution: Dr. Ron Shigeta’s Journey
Summary
Dr. Ron Shigeta, a pioneer in the biotech startup ecosystem, shares his insights and experiences in this episode. He discusses the success of IndieBio, a biotech accelerator that demonstrated the potential of modest investments in fueling biotech innovations.
Dr. Shigeta also highlights the importance of timing, luck, and having a clear vision in the biotech industry. He explains the diffe
From the Forest to your Pharmacy: Dr. Steven King’s Ethnobotanical Journey
In this enlightening episode of the RealPharma Podcast, hosts Ian Wendt and Dr. Nari Oh sit down with Dr. Steven King, a luminary in the field of ethnobotanical research and sustainable pharmaceutical development. Dr. King, currently serving as the Chief Sustainable Supply, Ethnobotanical Research, and IP Officer at Jaguar Health, shares his remarkable journey from a young adventurer in the Amazon
Command the Room: Dr. Laura Sicola’s Strategies for Executive Communication Excellence
Command the Room: Dr. Laura Sicola's Strategies for Executive Communication Excellence
Hosts: Dr. Na-Ri Oh and Ian Wendt
In this episode of the Real Pharma Podcast, we delve into the intricacies of effective executive communication with Dr. Laura Sicola, a renowned expert in leadership communication and cognitive linguistics. Dr. Sicola has spent over two decades transforming top-level executives
Drug Importation Debate: Ilisa Bernstein on the Global Pill
Summary
Ilisa Bernstein, a senior Vice President at the American Pharmacists Association, discusses the history and current landscape of drug importation policies with a focus on Florida's program.
Safety concerns, supply chain issues, and intellectual property rights are key considerations. The impact on the Canadian drug supply and the transparency of imported drugs for consumers are also discus
Navigating Your Biopharma Career: A Masterclass with Recruiter Kristiaan Rawlings
Summary
In this episode, Kristiaan Rawlings discusses the 2024-2025 Commercial Market Update and Salary Guide produced by EPM Scientific. The life sciences sector remains resilient due to aging populations, scientific advances, and robust investment. Hiring practices and compensation are influenced by these factors across the Americas, Europe, and APAC regions. The hiring focus has shifted from li
Pioneering Precision: Kira Dineen on Genetics’ Role in Tailored Therapies
Summary
In this episode, hosts Ian Wendt and Dr. Na-Ri Oh , and guest Kira Dineen discuss the intersection of genomics and healthcare. They explore the concept of personalized medicine and how advancements in genomics are revolutionizing healthcare. Kira shares her personal journey and the inspiration behind her DNA Today podcast. The conversation delves into the technology behind personalized med
Venture Capital & Biopharma: Jim Trenkle on Pioneering Health Innovation
Dive into the high-stakes world of Venture Capital in biopharma with Jim Trenkle! Have you ever wondered what it takes to turn groundbreaking scientific discoveries into life-saving treatments? What role do venture capitalists play in this thrilling journey from the lab to the clinic? This episode peels back the curtain on the biopharma venture capital scene, revealing the risks, rewards, and radi
Decoding HEOR: Iris Tam’s Insights on Pharma’s Value-Based Future
Join us on a deep dive into the world of Health Economics and Outcomes Research (HEOR) with the remarkable Iris Tam, PharmD, a luminary in value-based evidence generation within the biopharma industry. In this episode, our hosts Ian and Na-Ri explore with Iris the critical role of HEOR in transforming today's pharmaceutical landscape, from drug development to global marketing strategies and beyond
Redefining Fertility Care: Shelley Bailey’s Journey with Famlee
Dive into the world of fertility with Shelley Bailey, the visionary founder and CEO of Famlee Fertility, on our latest episode. Discover Shelley's personal journey that led to the creation of Famlee, a company revolutionizing the fertility landscape with its home-based testing and clinical treatments aimed at empowering women to understand and enhance their fertility.
In this enlightening conver
A Surgeon General’s Perspective: Dr. Adams on Health Innovation and Equity Challenges
Dr. Jerome Adams, the 20th US Surgeon General, discusses various topics related to public health, including Operation Warp Speed, diversity in clinical trials, improving healthcare access and outcomes, addressing health inequities, collaborative approaches in healthcare, challenges with pricing models, the importance of prevention and health literacy, and lessons learned from COVID-19.
In this con
Advocacy in Action: Coy Stout’s Vision for Empowered Healthcare
Trying to understand how pharma can effectively partner with patient advocates to support better patient outcomes?
In this episode, Coy Stout discusses his journey in patient advocacy and the intersection of patient advocacy, policy, and social work in the pharma industry. He shares personal stories that motivated him to get involved in the field and highlights the importance of patient-centricit
Engineering Health: Dr. Khalil Ramadi’s Vision of Bioengineering and Neuromodulation
Dr. Khalil Ramadi, an assistant professor at New York University Abu Dhabi, discusses the field of bioengineering and his work in neuromodulation and ingestible electronics. He explains that bioengineering encompasses tinkering with biology and physiology, and its focus has shifted from building hardware tools for the clinic to devices that can be implanted in the body.
Dr. Ramadi's interest in
Beyond the Job Title: Mastering the Pharma Job Market with Kristiaan Rawlings
This episode discusses the biopharmaceutical job market and the impact of the COVID-19 pandemic. It explores the state of the job market, including layoffs and hiring trends in the industry. The conversation also delves into the role of recruiters in the life sciences industry and provides insights into their day-to-day activities.
Additionally, it offers advice for candidates on how to approach
Navigating the Ethical Maze: Dr. Arthur Caplan on Bioethics in Modern Medicine
Dr. Arthur Caplan, a distinguished bioethicist, discusses various topics related to bioethics. He highlights the importance of bioethics in areas such as organ transplantation, genetic testing, artificial intelligence, and personalized medicine.
Dr. Caplan emphasizes the need for informed consent in research ethics and the importance of providing research participants with the results of studies.
Trailer
Coming January 2024! RealPharma Podcast is your gateway to the world of biopharmaceuticals and healthcare. Your hosts are two industry veterans who engage in in-depth conversations with pharma pathfinders/leaders who are shaping the future of medicine. Hear the stories behind the news that challenge traditional viewpoints and offer fresh perspectives that will make you rethink what you know about
Recommended
The Bread and Banter Podcast
Solved Murders - True Crime Stories
紐約鳥｜New York Aperture
Stand In The Circle
Doctor Zhivago Slow Read
The Swerve Podcast: Obscure Topics | Conspiracy Theories
The Young and Called Podcast .
Conspiracy Files with Paige Carter
World News Tonight with David Muir
Bad Friends
Iran War Daily
MosaLingua Language Lab
